New company launches patented clean-air technology capable of destroying viruses and removing harmful particulates at unprecedented levels

A new clean-air technology company today announced its official launch alongside the introduction of Sterilize-Aer, a patented, future-ready, air treatment platform designed to actively destroy airborne pathogens and remove harmful environmental particulates at a level unmatched by existing solutions.

Sterilize-Aer has been independently validated to destroy and remove 99.9% of airborne viruses and biological pathogens, while also eliminating PM10, PM2.5 and sub-micron particulates, including nano-plastics generated by traffic and industrial activity. This dual capability makes the company the only provider of a single, integrated technology proven to address both biological and environmental airborne threats.

Designed to go beyond conventional air filtration, Sterilize-Aer actively treats air rather than simply trapping contaminants. The system targets viruses, bacteria, allergens, fungal spores and hazardous particulates through a multi-stage, sequential process, with each stage engineered to address a specific class of airborne contaminant. A built-in fail-safe architecture ensures continued protection even if one stage is compromised, delivering uninterrupted performance in critical environments.

The technology has been developed to support sectors where air quality is mission-critical, including hospitals and healthcare settings, public transport networks, offices, schools, airports, shopping centres, care homes, hospitality venues and cinemas-allowing occupants to operate with greater confidence in the air they breathe.

Backed by awarded and pending patents and supported by rigorous third-party testing, Sterilize-Aer has been validated through collaborations with the University of Ulster (School of Biomedical Sciences), the National Physical Laboratory (NPL), and AirMid Healthgroup Limited. Using non-pathogenic surrogate organisms to ensure safety, testing confirmed the system’s ability to achieve a minimum five-log reduction in airborne pathogens and particulates, with modelling indicating potential reductions exceeding nine log levels, subject to further trials.

Unlike traditional HEPA filtration or UV-based air treatment systems, Sterilize-Aer operates without consumable filters, significantly reducing maintenance requirements and operational disruption. Its self-cleaning, fully automated design enables continuous background operation with minimal intervention. The absence of airflow-restrictive filters also delivers substantial efficiency gains, with energy savings of up to 90% compared with conventional HVAC filtration, making retrofitting into existing infrastructure both technically and financially viable.

By addressing the limitations of existing air treatment technologies-such as pressure loss, high energy demand, size constraints and potential health risks-the new company positions Sterilize- Aer as the most comprehensive clean-air solution currently available, capable of mitigating viral transmission, long-term particulate exposure and harmful gaseous pollutants in a single system.

“This launch marks a significant step forward in how we protect people from airborne health risks,” said a Neil Duffield, a director of the company. “Sterilize-Aer is not just a response to recent global health challenges; it is a long-term, scalable solution to the persistent problem of poor air quality in shared spaces.”

With growing regulatory, environmental and public health pressures around air quality, the company believes Sterilize-Aer offers organisations a robust, validated and future-proof platform to protect occupants, improve wellbeing and reduce operational costs-without compromise.